We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
To own DuPont today, you need to believe the reshaped company can turn its tighter focus on healthcare and water into steadier, higher quality earnings despite legal and portfolio risks. The successful Qnity separation and higher volume-driven third quarter help the near term story, but they do not materially change the most important catalyst, which is execution in healthcare and water, or the biggest risk, which remains PFAS and related environmental liabilities.
The new US$2,000 million share repurchase program is the announcement that stands out here, because it directly affects how existing shareholders participate if DuPont can translate its post-Qnity portfolio into more resilient cash flows. While it does not remove the legal, diversification, or pricing pressures flagged earlier, it does frame near term capital returns as part of the thesis around a more focused, higher margin New DuPont.
However, investors should also weigh the unresolved PFAS liability exposure, because...
Read the full narrative on DuPont de Nemours (it's free!)
DuPont de Nemours' narrative projects $14.0 billion revenue and $1.7 billion earnings by 2028. This requires 3.7% yearly revenue growth and about a $1.63 billion earnings increase from $71.0 million today.
Uncover how DuPont de Nemours' forecasts yield a $47.25 fair value, a 15% upside to its current price.
Four fair value estimates from the Simply Wall St Community cluster between US$41.13 and US$47.25, showing how differently people view DuPont’s prospects. As you compare those views, remember that the key short term catalyst now is whether the refocused healthcare and water portfolio can offset legal and portfolio concentration risks that could shape the company’s performance for years.
Explore 4 other fair value estimates on DuPont de Nemours - why the stock might be worth just $41.13!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com